Colorado
How Enright v. Eli Lilly & Co. applies in Colorado: state-specific rules, key cases, and bar exam notes for Other.
In Colorado, the principles derived from Enright v. Eli Lilly & Co. influence the evaluation of liability in pharmaceutical litigation regarding whether sufficient evidence supports claims of negligence and strict liability. Colorado courts closely scrutinize expert testimony related to causation and the adequacy of warnings.
In Colorado, a plaintiff must demonstrate that a product was defectively designed or lacked adequate warnings, and that such defect was a proximate cause of the injury sustained.
The court held that a plaintiff must provide specific evidence linking the product defect to the claimed injury to establish liability.
The court emphasized the importance of expert testimony in establishing the existence and impact of product defects in strict liability cases.
The court ruled that in strict products liability, a plaintiff must show both the defectiveness of the product and the manufacturer's failure to warn of foreseeable risks.
Colorado's approach largely mirrors the federal standard, particularly regarding the necessity of proving causation and the presentation of expert testimony. However, Colorado may impose stricter requirements for the admissibility of expert opinions on whether a drug's risks outweighed its benefits.
Questions on Colorado's tort and product liability laws are relevant to the bar exam, often focusing on the nuances of case law such as Enright v. Eli Lilly & Co. and its implications in determining liability.